0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial | 
Stephen L. Hauser, MD
JAMA. 2015;313(3):251-252. doi:10.1001/jama.2014.18150.

Preliminary Communication | 
Richard K. Burt, MD; Roumen Balabanov, MD; Xiaoqiang Han, MD; et al.
JAMA. 2015;313(3):275-284. doi:10.1001/jama.2014.17986.
Includes: Supplemental Content

Original Investigation | 
Nikolai Madrid Scheller, MB; Henrik Svanström, MSc; Björn Pasternak, MD, PhD; et al.
JAMA. 2015;313(1):54-61. doi:10.1001/jama.2014.16946.
Includes: Supplemental Content

news@JAMA | 
JAMA. 2014;311(13):1281. doi:10.1001/jama.2014.2920.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(8):790. doi:10.1001/jama.2014.1553.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(16):1666. doi:10.1001/jama.2013.281116.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2013;309(5):431. doi:10.1001/jama.2013.267.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2012;308(24):2557. doi:10.1001/jama.2012.156146.

Viewpoint | 
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA. 2012;308(9):869-870. doi:10.1001/jama.2012.9658.

Editorial | 
Tobias Derfuss, MD; Ludwig Kappos, MD
JAMA. 2012;308(3):290-291. doi:10.1001/jama.2012.8327.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Viewpoint  | 
How Critical Is the Blood-Brain Barrier to the Development of Neurotherapeutics?
Carmen Kut, BS; Stuart A. Grossman, MD; Jaishri Blakeley, MD
JAMA Neurology
Editorial  | 
Treatment Decisions for Patients With Active Multiple Sclerosis
Olaf Stüve, MD, PhD; Diego Centonze, MD, PhD
JAMA Neurology
Original Investigation  | 
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis
Anna He, MBBS; Tim Spelman, MBBS, MSc; Vilija Jokubaitis, PhD; et al.
JAMA Neurology
Original Investigation  | 
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis
Keita Takahashi, MD; Yuji Kurihara, PhD; Yume Suzuki, MD, PhD; et al.